AUTOIMMUNE HEMOLYTIC ANEMIA

Clinical trials for AUTOIMMUNE HEMOLYTIC ANEMIA explained in plain language.

Never miss a new study

Get alerted when new AUTOIMMUNE HEMOLYTIC ANEMIA trials appear

Sign up with your email to follow new studies for AUTOIMMUNE HEMOLYTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 5 Not yet finished but already full! 1 Completed 3 Terminated 1

Experimental drug for rare blood disorder shows early promise but study halted

Disease control Terminated

This early-stage study tested a drug called Linperlisib in 4 adults with autoimmune hemolytic anemia (AIHA) whose disease did not respond to at least two prior treatments. The goal was to see if the drug could improve red blood cell counts and reduce symptoms. The study was termi…

Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA

Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated May 17, 2026 04:14 UTC

AUTOIMMUNE HEMOLYTIC ANEMIA

Get alerted when new AUTOIMMUNE HEMOLYTIC ANEMIA trials appear

Experimental drug for rare blood disorder shows early promise but study halted